-+ 0.00%
-+ 0.00%
-+ 0.00%

Elite Pharmaceuticals Director Barry H. Dash Reports Acquisition of $25,980 in Common Shares

PUBT·10/19/2026 10:16:10
Elite Pharmaceuticals Director Barry H. Dash Reports Acquisition of $25,980 in Common Shares
  • Elite Pharmaceuticals director Barry H. Dash purchased 100,000 common shares at $0.2598 each.
  • His direct beneficial ownership rose to 3,365,555 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elite Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047486), on October 19, 2026, and is solely responsible for the information contained therein.